AAAAAA

   
Results: 1-12 |
Results: 12
AXILLARY STAGING OF T1-T2 BREAST-CANCER
Authors: SANDRUCCI S SORBA P BELLO W DANESE S ROAGNA R DURANDO A GIANI R AIDALA S CLARA R FILIPPI A PELLERITO R SILVESTRO L CALDERINI P GIARDINA G MASSOBRIO M SISMONDI P BISI G MUSSA A FAVERO G MUSSA GC
Citation: S. Sandrucci et al., AXILLARY STAGING OF T1-T2 BREAST-CANCER, European journal of cancer, 34, 1998, pp. 315-315
P53 AND WAF1 EXPRESSION IN EPITHELIAL OVARIAN-CANCER - PROGNOSTIC ANDPREDICTIVE IMPLICATIONS
Authors: KATSAROS D GENTA F DURANDO A DANESE S RICCHIARDI R LEVESQUE M DIAMANDIS EP MASSOBRIO M
Citation: D. Katsaros et al., P53 AND WAF1 EXPRESSION IN EPITHELIAL OVARIAN-CANCER - PROGNOSTIC ANDPREDICTIVE IMPLICATIONS, European journal of cancer, 34, 1998, pp. 106-106
PACLITAXEL ON DAY 1 AND 8 IN PRETREATED PATIENTS WITH METASTATIC BREAST-CANCER - PRELIMINARY-RESULTS
Authors: DONADIO M MANZIN E BERRUTI A BOTTINI A RICHIARDI G DANESE S CASTIGLIONE F DEFABIANI E DOGLIOTTI L BUMMA C
Citation: M. Donadio et al., PACLITAXEL ON DAY 1 AND 8 IN PRETREATED PATIENTS WITH METASTATIC BREAST-CANCER - PRELIMINARY-RESULTS, Annals of oncology, 9, 1998, pp. 96-96
SEQUENTIAL EPIDOXORUBICIN AND PACLITAXEL AS PRIMARY CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST-CANCER
Authors: GIARDINA G DANESE S BELLINO R KATSAROS D DESANCTIS C DURANDO A RICHIARDI G ARESE P GENTA F
Citation: G. Giardina et al., SEQUENTIAL EPIDOXORUBICIN AND PACLITAXEL AS PRIMARY CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST-CANCER, Annals of oncology, 9, 1998, pp. 108-108
CISPLATIN, EPIRUBICIN, AND LONIDAMINE COMBINATION REGIMEN AS FIRST-LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER - A PILOT-STUDY
Authors: DOGLIOTTI L DANESE S BERRUTI A ZOLA P BUNIVA T BOTTINI A RICHIARDI G MORO G FARRIS A BAU MG PORCILE G
Citation: L. Dogliotti et al., CISPLATIN, EPIRUBICIN, AND LONIDAMINE COMBINATION REGIMEN AS FIRST-LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER - A PILOT-STUDY, Cancer chemotherapy and pharmacology, 41(4), 1998, pp. 333-338
ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER
Authors: PARMAR MKB TORRI V BONAVENTURA A BONAZZI C COLOMBO N DELALOYE JF MARSONI S MANGIONI C SANDERCOCK J SESSA C WILLIAMS C TINAZZI A FLANN M GEISER K SCORPIGLIONE N STEWART JF CHAVES J PALMEIRO E CURTAIN A MCCORMACK T GENNATAS C MARRAS F OPPO TG BALESTRINO M MALZONI C MALZONI M BELLI M GEMINIANI ML CRESTANI G MONACO A VAVALA V PIATTO E BARATTINI G FORNARA PG CHETRI MC SANTEUFEMIA G ARTIOLI F CARONE D FANIZZA G TRENTADUE R PRIOLO D SCOLLO P NIGRO SC PETRINA M MASTRANTONIO P SPANNA GD ZAGNI R BELLONI C COLLEONI R REDAELLI L CAVAGNINI A DICOSTANZO G PERRONI D ARIENTI S ORFANOTTI G CANTONI FM SECLI R BIANCHI A MARTINELLO R MOLLICA G MAIZZI D PICCHIARELLI ME FIORINI G BORSANI M COLOMBO E GARSIA S MELGRATI L PAGGI G BRUNENGHI GM CASINI M ISA L ALGERI R PROZIO G BELFIORE G ANGELINI F DAPRILE M MORESCHI M MAURI ML NATALE N SENZANI FM PAVANATO G POGGI G GARUTI G LUERTI M CRUCIANI G PAGANO F BACCOLO M PODDI ER BOCCIOLONE L SABELLI MA MAGGI R RESTELLI C DANTONA A LOCATELLI MC PESSI A RAINA A CHIARI S GABRIELE A PITTELLI MR IACOBELLI P DOGLIOTTI L GORZEGNO G MUSSO P VEGNA G COCO G ALLETTI DG PICCIOTTO F LUCCHESE V EPIS A DIPALUMBO VS DRUDI G RAVAIOLI A ZAMPELLA D MORANDI MG GORGA G ZUCCHELLI C CARIELLO S GALLETTO L SUSSIO M MASSACESI L MASSACESI M CARLI A TUCCI E TAJANI E CORRADO G BUMMA S DURANDO A MASSOBRIO M SBERVEGLIERI M BIASIO M GUERCIO E JURA R DANESE S WIERDIS T FARNELLI C TARANTINO G GRASSI R REPETTI F ROCCHI B GRAMPA M ERCOLI A GRISO C SIGNORI E ZANINI L PRESTI M KLIMEK M URBANSKI K BISWAS A VIEGAS O KOCHLI O DREHER E FEY M BECK G LUDIN J BONNEFOI H KRAUER F BAUER J DELMORE G FURRER C LORENZ U THURLIMANN B LORENZ U BRONZ L SANNA P WYSS D GOLDHIRSCH A GYR T LEIDI L PASTORELLI G PAGANI O REY P HAILER U BENZ J KAYE SB REED NS SYMONDS RP ATKINSON RJ AXFORD AT RUSTIN G SECKL MJ GREEN JA SCOTT IV GUTHRIE D HARPER PG CALMAN F DOBBS HJ WEIR P CASSONI A LEDERMAN JA SOUHAMI RL BOZZINO J ADAB F REDMAN CWE SCOBLE JE PATERSON M DANIEL F COWLEY N WILLIAMS CJ SPOONER D HONG A MCILLMURRAY M HENDYIBBS P HALL V IVESON TJ WHITEHOUSE JMA GARRY R LAMONT A ROBINSON A TRASK CW CLUBB AW MURRELL D NEWMAN G WILKINS M GOLDTHORP WO ROBERTS JK RADSTONE DJ WHIPP MJ LEDERMANN JA PATER J BUYSE M OMURA G
Citation: Mkb. Parmar et al., ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER, Lancet, 352(9140), 1998, pp. 1571-1576
THE CLINICAL PREDICTIVITY OF BIOMARKERS OF STAGE III-IV EPITHELIAL OVARIAN-CANCER IN A PROSPECTIVE RANDOMIZED TREATMENT PROTOCOL
Authors: SILVESTRINI R DAIDONE MG VENERONI S BENINI E SCARFONE G ZANABONI F VILLA A PRESTI M DANESE S BOLIS G
Citation: R. Silvestrini et al., THE CLINICAL PREDICTIVITY OF BIOMARKERS OF STAGE III-IV EPITHELIAL OVARIAN-CANCER IN A PROSPECTIVE RANDOMIZED TREATMENT PROTOCOL, Cancer, 82(1), 1998, pp. 159-167
PREDICTIVE VALUE OF THE SENTINEL NODE BIOPSY IN AXILLARY STAGING OF T1-T2 BREAST-CANCER - A PRELIMINARY EXPERIENCE
Authors: SANDRUCCI S BELLO M DANESE S GIAI M GIANI R DANESE F BERTUCCIO G GRECO B SORBA P CALDERINI P SISMONDI P GIARDINA G BOCCI A BISI G MUSSA A
Citation: S. Sandrucci et al., PREDICTIVE VALUE OF THE SENTINEL NODE BIOPSY IN AXILLARY STAGING OF T1-T2 BREAST-CANCER - A PRELIMINARY EXPERIENCE, Breast, 6(5), 1997, pp. 314-314
ANTIEMETIC EFFICACY OF GRANISETRON IN PATIENTS WITH GYNECOLOGICAL MALIGNANCIES
Authors: SISMONDI P DANESE S GIARDINA G GUERCIO E RICHIARDI G CARNINO F FERRARIS C LISSONI A INGANNI P MAGGI R BOCCARDO E BARBIERI P
Citation: P. Sismondi et al., ANTIEMETIC EFFICACY OF GRANISETRON IN PATIENTS WITH GYNECOLOGICAL MALIGNANCIES, Anti-cancer drugs, 8(3), 1997, pp. 225-230
WEEKLY CISPLATIN GIVEN FOR 2 MONTHS VERSUS CISPLATIN PLUS CYCLOPHOSPHAMIDE GIVEN FOR 5 MONTHS AFTER CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN-CANCER
Authors: BOLIS G FAVALLI G DANESE S ZANABONI F MANGILI G SCARABELLI C TATEO S VALSECCHI MG SCARFONE G RICHIARDI G FRIGERIO I MELPIGNANO M VILLA A PARAZZINI F
Citation: G. Bolis et al., WEEKLY CISPLATIN GIVEN FOR 2 MONTHS VERSUS CISPLATIN PLUS CYCLOPHOSPHAMIDE GIVEN FOR 5 MONTHS AFTER CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 15(5), 1997, pp. 1938-1944
WEEKLY CISPLATIN AS NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL-CANCER - A WELL-TOLERATED ALTERNATIVE
Authors: GIARDINA G RICHIARDI G DANESE S OTTONE P OHLMEIER U GARGIULO T
Citation: G. Giardina et al., WEEKLY CISPLATIN AS NEOADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL-CANCER - A WELL-TOLERATED ALTERNATIVE, European journal of gynaecological oncology, 18(3), 1997, pp. 173-176
INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL
Authors: DELTURCO MR PALLI D CARIDDI A CIATTO S PACINI P DISTANTE V AZZINI V BELSANTI V BARTOLUCCI R DICOSTANZO F BERTUSI M DANESE S GIARDINA G DAIUTO G UCCELLO V DELEO G PUNZO C GOSSO P GRISO C LOCATELLI E MANSUTTI M SANDRI P MOLINO AM SCHINCAGLIA P TIENGHI A
Citation: Mr. Delturco et al., INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL, JAMA, the journal of the American Medical Association, 271(20), 1994, pp. 1593-1597
Risultati: 1-12 |